Back to mobile site

More on RNAZ

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/17/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

TransCode Therapeutics (NQ:RNAZ)
Delayed: 1.72 +0.04 (2.38%)
Prev. Close $1.68  
Open$1.70 
52 Wk High$ 
52 Wk Low$ 
Day High$1.72 
Day Low$1.63 
P/E N/A  
EPS$ 
Volume47,129 

Friends, Peers and Foes (?): VRAX (more...)

Sep 16, 2026 09:01 AM Join Today's Live Investor Webinar with TransCode Therapeutics
Sep 11, 2026 05:10 PM Form 4 Transcode Therapeutics, For: Sep 09 Filed by: Fitzgerald Thomas A
Sep 11, 2026 05:01 PM Form 8-K Transcode Therapeutics, For: Sep 09
Sep 10, 2026 04:13 PM TransCode Therapeutics CFO Tom Fitzgerald retires, replaced interim
Sep 10, 2026 04:10 PM TransCode Therapeutics Announces Leadership Transition
Sep 3, 2026 09:00 AM Join TransCode Therapeutics' Live Investor Webinar: Advancing a Multi-Platform Oncology Pipeline Targeting Metastatic Cancer
Aug 14, 2026 05:06 PM Form 10-Q Transcode Therapeutics, For: Jun 30
Aug 7, 2026 09:01 AM Virax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
Aug 5, 2026 04:06 PM Form 4 Transcode Therapeutics, For: Aug 03 Filed by: CK Life Sciences Intl (Holdings) Inc
Aug 5, 2026 04:06 PM Form 3 Transcode Therapeutics, For: Jul 27 Filed by: CK Life Sciences Intl (Holdings) Inc
View All Articles

Entities mentioned with RNAZ

View All Entities